First National Bank Alaska heads into the final day of April with an intriguing split: the stock has quietly rallied while borrowing costs have risen sharply to multi-year highs.
The clearest tension in the data is in the lending market. Cost to borrow has climbed to 10.29% — up 25% week-on-week and 30% over the past month. That is the highest borrow rate in the available history, meaningfully above the 6–8% range that prevailed through most of 2025. The absolute short position remains tiny — just 48 shares as of April 28, up from 2 shares earlier in the month — but it is worth noting that the sharp jump in the week-on-week change figure (a reported 2,300%) reflects that mid-April trough rather than a genuine institutional short-selling campaign. Despite the noise, the borrow cost move is real and sustained. Availability, however, remains exceptionally loose at 1,130% of short interest, meaning there is no squeeze pressure in the lending pool and the elevated cost reflects thin market dynamics on an illiquid OTC name rather than a crowded short.
The stock itself is in good shape. FBAK closed Wednesday at $330.99, up 2.4% on the week and 10.9% over the past month — a run that has pushed the RSI14 to 64, a mildly elevated but not overbought reading. Days to cover remains negligible at 0.26, and the DTC rank of 83 reflects how the stock screens as relatively well-positioned within its peer group on this metric. There are no analyst ratings or price targets on the name — unsurprising for a thinly followed OTCPK-listed community bank — so price discovery is driven entirely by fundamentals and natural buyers.
Institutional ownership tells a concentrated story. Only four holders appear in the data, the largest being Royce & Associates and Kahn Brothers Advisors with roughly 0.16% and 0.16% of shares respectively, both as of December 2025. Both trimmed slightly in that period — Royce cut 550 shares, Kahn dropped 70 — suggesting modest profit-taking rather than conviction selling. With a market cap around $1 billion, FBAK sits in the upper end of small-cap territory, and its OTC listing keeps it off the radar of most institutional screens. The dividend history is stale beyond April 2022, so no yield signal can be drawn from the available data.
Recent earnings reactions have been subdued. The last four events produced 1-day moves of +2.2%, -1.7%, +0.7%, and +0.6% respectively. Five-day moves were similarly contained, the largest being +5.4% after the August 2025 print. The next scheduled event is a full-year results announcement; no confirmed date has been set. Peers in the correlation model — BAC declined slightly on the week while the broader group softened — diverged from FBAK's positive price action, underlining the stock's low-beta, independent character.
The setup to watch is whether the rising cost to borrow persists. On a name this thinly traded, CTB can move sharply on very small demand. If borrow costs continue climbing while the share count of shorts stays in the low dozens, that is a structural quirk of the lending market rather than a fundamental signal. What matters more is whether the price momentum above $330 holds as the bank approaches its next earnings disclosure.
See the live data behind this article on ORTEX.
Open FBAK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
